AXSM · Axsome Therapeutics, Inc. · Documents
$145.04
-11.03 (-7.07%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$7.60B
Shares
52.38M
Volume · Oct 23
1.59M
Avg daily vol (3M)
738.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-11-12 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-10-01 | 2024-09-30 | |
| 8-K | — | 2024-09-04 | — | |
| 8-K | — | 2024-08-21 | — | |
| 10-Q | — | 2024-08-05 | 2024-06-30 | |
| 8-K | — | 2024-08-05 | — | |
| 8-K | — | 2024-06-11 | 2024-06-07 | |
| 8-K | — | 2024-06-05 | — | |
| 8-K | — | 2024-05-06 | — | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| DEF 14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-01 | 2024-03-28 | |
| 8-K | — | 2024-03-25 | — | |
| 8-K | — | 2024-03-25 | — | |
| 8-K | — | 2024-03-19 | — | |
| 10-K | — | 2024-02-23 | 2023-12-31 | |
| 8-K | — | 2024-02-20 | — | |
| 8-K | — | 2024-02-20 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2024-01-04 | — | |
| 8-K | — | 2023-12-07 | — | |
| 8-K | — | 2023-11-06 | — | |
| 10-Q | — | 2023-11-06 | 2023-09-30 | |
| 8-K | — | 2023-10-11 | 2023-10-08 | |
| 8-K | — | 2023-08-15 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-08-04 | — | |
| 8-K | — | 2023-07-07 | — | |
| 8-K | — | 2023-06-30 | — | |
| 8-K | — | 2023-06-29 | 2023-06-27 | |
| 8-K | — | 2023-06-26 | 2023-06-22 | |
| 8-K | — | 2023-06-13 | — | |
| 8-K | — | 2023-06-08 | 2023-06-02 | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | — | |
| DEF 14A | — | 2023-04-21 | — | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-03-10 | — | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-02-27 | — | |
| 8-K | — | 2023-02-22 | 2023-02-21 | |
| 8-K | — | 2023-02-13 | 2023-02-10 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-11-28 | — | |
| 8-K | — | 2022-11-14 | — | |
| 10-Q | — | 2022-11-07 | 2022-09-30 | |
| 8-K | — | 2022-11-07 | — | |
| 8-K | — | 2022-10-20 | — |
Showing 51–100 of 187 filings
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
67 filings
63 filers
Visit website
Investor relations